Scientists Are Pursuing the Dream of a 'Virtual Cell' ...Middle East

News by : (Time) -
—Sciepro—Science Photo Library—Getty Images

With a virtual cell, biologists imagine, you could switch off a gene involved in a disease, or add an experimental drug, and then watch how the cell changes. Such a model, which many observers think would have to involve AI, could help generate ideas for new treatments. It might suggest promising hypotheses to explore in live cells, or speed up the lengthy process of drug discovery. 

Three times as many teams as last year—about 1,000 in total—competed in the final judging, says contest head Hani Goodarzi, AI research lead at the Arc Institute and a professor of biochemistry at the University of California, San Francisco, suggesting a significant rise in interest and resources aimed at the problem. “It's a staggering number of participants,” he says. “This year, everyone jumped in.”

In 2020, AlphaFold, an AI system developed by Google DeepMind, won first place in a competition to predict the final folded shape of a protein, a hard problem in biology. Shocked and intrigued, scientists began to wonder what other problems such tools could solve. 

For this year’s Virtual Cell Challenge, the organizers asked for just part of what a virtual cell might eventually deliver: a prediction of what happens to cells when genes are switched off. That’s the kind of experiment science has collectively spent hundreds of millions of dollars on, says Goodarzi. “If you think about, similar to AlphaFold, replacing something that's very slow and expensive with a reliable in silico simulation”—meaning a computer simulation—“that is like the north star for us, for at least this phase,” he says. The hope is that figuring out this question will one day lead to advances like better, faster drug discovery.

More data mean better predictions 

More than 1,600 teams, including individual academic labs and groups from biotechnology companies, submitted models in the early phases of the competition, according to Goodarzi. About a thousand teams submitted the predictions made by their models for the final phase. 

Khodaveisi, whose background is machine learning, describes their model as a team of three parts. “One decides what changes in the cell, another decides how big the impact is, and the last decides the direction of the change,” he says. “This is what makes our model interesting—we could see the reasoning behind it.”

“As a community, we need to generate more and more data,” says Goodarzi, “to allow the models to generalize better and better.”

How can researchers get more data?

The escalation is already underway. In April, Biohub—a nonprofit biomedical research organization backed by the Chan Zuckerberg Initiative—announced a new Virtual Biology Initiative, a five-year program to generate data that could be used in virtual cell models. In July, the U.S. National Institutes of Health announced the Bio Genesis Mission, which will also create such data. “In the next 18 months, we think we can increase the amount of available relevant data by about tenfold as a start,” says Kelley. “Then we'll keep going from there.” 

Goodarzi and his colleagues at the Arc Institute are already preparing for next year’s Virtual Cell Challenge, which will begin in the summer. “We are going to run this indefinitely, every year,” he says. “Until we have a virtual cell.”

Hence then, the article about scientists are pursuing the dream of a virtual cell was published today ( ) and is available on Time ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Scientists Are Pursuing the Dream of a 'Virtual Cell' )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار